Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales
Marketline
Resource access
Open the content from the main option or choose another available source.
Institutional access available
How to cite
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
Marketline (s. f.). Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site
MLA
Marketline. Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site.
Chicago
Marketline. s. f. Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site.
Harvard
Marketline s. f, Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales, Marketline, available at: https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site [Accessed 8 Aug. 2026].
Resource details
Bibliographic information to help confirm that this is the correct material.
- Title
- Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales
- Author / contributors
- Marketline
- Publisher
- Marketline